Fine Organics gains Thai control through Rs 80.17 crore deal
Key highlights
- Fine Organics completed the Rs 80.17 crore acquisition of 80% of OFM on September 9, 2026.
- Fine Organics said its direct and indirect voting control in FOIT is about 53%, compared with its prior 45% direct stake.
- H1 FY27 consolidated revenue increased 20.1% year on year to Rs 1,423.6 crore.
- Fine Organics invested Rs 55 crore in its SEZ subsidiary in Q2 FY27, taking cumulative investment to Rs 247.5 crore.
powered by IRIS

Fine Organic Industries Limited completed its Rs 80.17 crore acquisition of 80% of Malaysia-based Oleofine Organics Sdn. Bhd. on September 9, 2026, making the Malaysian company a subsidiary and giving Fine Organics direct and indirect control of about 53% of voting power in its Thai specialty-chemicals business.
Know Fine Organic Industries inside out
Results, valuation, peers and who's buying, in one view.
How did Fine Organics acquire Oleofine Organics Malaysia?
Fine Organics acquired 80% of Oleofine Organics Sdn. Bhd., or OFM, for a total cost of Rs 80.17 crore, completing the process on September 9, 2026. OFM is incorporated in Malaysia and operates in specialty chemicals, which places the acquired business within Fine Organics’ stated area of activity in specialty plant-derived oleochemical-based additives.
The 80% holding was assembled from two seller groups. Fine Organics bought 50% from Smoothex Chemicals Pvt. Ltd. and the remaining 30% from other OFM shareholders. This transaction structure made OFM a subsidiary of Fine Organics, while the investor release does not disclose a separate valuation for the two blocks of shares or the commercial terms for the remaining 20% interest.
Management said the transaction is in line with the company’s growth strategy. The release does not provide OFM’s revenue, profit, assets, customer base, manufacturing capacity or planned integration steps, so the disclosed evidence establishes the ownership change and purchase cost rather than a quantified earnings contribution.
How did the Malaysia deal make Fine Organics control FOIT?
Fine Organics said the OFM acquisition changed Fine Organic Industries (Thailand) Co., Ltd., or FOIT, from a joint venture into a subsidiary because the company and OFM together control more than half of FOIT’s voting power. FOIT is incorporated in Thailand and is engaged in specialty chemicals, which Fine Organics identifies as being within its main business line.
Before the acquisition, Fine Organics held a direct 45% stake in FOIT. OFM holds a further 10% stake, so the acquisition of 80% of OFM added indirect voting influence over that Thai stake. Fine Organics stated that it directly or indirectly controls about 53% of FOIT’s total voting power and therefore treats FOIT as a subsidiary under Section 2(87) of the Companies Act, 2013.
The change matters because it extends the transaction beyond the 80% Malaysian holding. Fine Organics now reports a controlled-subsidiary relationship for both OFM and FOIT, whereas FOIT had previously been described as a joint venture. The release does not state whether Fine Organics obtained new board, operating or distribution rights at FOIT, nor does it quantify FOIT’s financial contribution following the classification change.
What was Fine Organics’ financial position when the deal closed?
Fine Organics reported consolidated revenue from operations of Rs 1,423.6 crore in H1 FY27, up 20.1% from Rs 1,185.7 crore in H1 FY26. Earnings before interest, tax, depreciation and amortisation, or EBITDA, rose 39.5% to Rs 360.9 crore, while profit after tax, or PAT, increased 28.6% to Rs 290.3 crore.
The first-half comparison shows that profit and operating earnings grew faster than revenue. EBITDA margin increased to 25.4% in H1 FY27 from 21.8% in H1 FY26, a rise of 3.6 percentage points, while PAT margin rose to 20.4% from 19.0%, a 1.4-percentage-point increase. These are consolidated results and are not presented as an acquisition-only effect, since the OFM transaction completed late in the reported half year.
In Q2 FY27, revenue was Rs 729.4 crore, up 22.1% from Rs 597.3 crore in Q2 FY26. EBITDA increased 36.8% to Rs 184.9 crore and PAT rose 40.1% to Rs 152.1 crore. Fine Organics’ release places the Malaysian transaction within this quarter, but it does not split Q2 results between the existing business, OFM and FOIT.
Got a follow-up? Ask IRIS
What cost and demand conditions did Fine Organics report?
Fine Organics said demand remained stable in H1 FY27, alongside improved revenue performance of Rs 1,423.6 crore. Exports accounted for about 58% of first-half revenue and domestic demand for 42%, showing that overseas markets remained the larger sales component during the period that included the September 2026 acquisition.
The Q2 FY27 mix was somewhat more domestic than the first-half mix. Exports represented 56% of Q2 revenue and domestic business represented 44%, compared with 58% and 42%, respectively, for H1 FY27. The release does not give country-level export data or identify whether Malaysia or Thailand were material destinations before the acquisition.
The company also reported substantially higher raw-material prices in H1 FY27 than in H1 FY26. Raw-material prices increased only marginally in Q2 FY27 compared with Q1 FY27, according to the release. This contrast indicates that year-on-year input-cost pressure persisted even as the quarter-on-quarter increase moderated.
What other capital commitments and events should readers track?
Fine Organics infused Rs 55 crore into wholly owned Fine Organic Industries (SEZ) Pvt. Ltd. during Q2 FY27 through 1% non-convertible, non-cumulative, non-participating redeemable preference shares. The infusion brought cumulative investment in the subsidiary to Rs 247.5 crore, against an already approved Rs 300 crore equity infusion.
The board additionally approved Rs 120 crore of equity infusion in the SEZ subsidiary for its ongoing project. The investor release does not give the project’s completion date, capital expenditure profile, capacity or expected returns. This separate commitment is relevant alongside the Rs 80.17 crore OFM acquisition because both involve deployment of capital into subsidiaries during FY27.
Fine Organics also reported a final Rs 4.35 crore insurance settlement in July 2026 for property damage and inventory losses from the January 2024 Badlapur plant fire. Earlier interim settlements totalled Rs 1.80 crore, and the company said the business-interruption claim had already been received in the quarter ended June 30, 2025. It made the necessary accounting adjustments in standalone financial statements for the quarter ended June 30, 2026.
Conclusion
The Rs 80.17 crore purchase gives Fine Organics an 80% Malaysian specialty-chemicals subsidiary and changes its relationship with FOIT by establishing stated direct and indirect voting control of about 53%. The ownership outcome is broader than a single Malaysian acquisition: it converts the Thai operation from a joint venture into a subsidiary while H1 FY27 consolidated revenue rose 20.1% to Rs 1,423.6 crore.
Next, readers can watch for disclosures on OFM and FOIT financial consolidation, including revenue, profit and operating integration, which the September 2026 release does not quantify. Fine Organics also has Rs 52.5 crore remaining under its earlier Rs 300 crore SEZ approval, as well as a further Rs 120 crore board-approved infusion for the ongoing SEZ project, without a disclosed project timetable.


